Weitz Investment Management - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Weitz Investment Management ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q3 2015$112,407,000
-29.4%
630,155
-12.1%
3.48%
-22.0%
Q2 2015$159,222,000
-12.6%
716,730
-21.9%
4.47%
-9.2%
Q1 2015$182,186,000
-7.7%
917,261
-33.5%
4.92%
-10.7%
Q4 2014$197,292,000
-11.1%
1,378,606
-18.5%
5.51%
-15.6%
Q3 2014$221,928,000
+13.4%
1,691,525
+9.1%
6.53%
+10.5%
Q2 2014$195,622,000
-7.1%
1,551,076
-2.9%
5.91%
-12.2%
Q1 2014$210,604,000
-3.0%
1,597,540
-13.6%
6.73%
-7.5%
Q4 2013$217,096,000
+1.9%
1,849,200
-9.5%
7.28%
-9.3%
Q3 2013$213,129,000
+18.2%
2,042,835
-2.5%
8.02%
+9.9%
Q2 2013$180,357,0002,095,2307.30%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders